Why Did Bill Ackman Buy Uber Stock?
In February, Pershing Square manager Bill Ackman revealed that his…
Sell
32
ACXP Quote, Financials, Valuation and Earnings
Last price:
$0.41
Seasonality move
:
3.03%
Day range:
$0.39 - $0.40
52-week range:
$0.30 - $3.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
14.39x
Volume:
116.4K
Avg. volume:
150.4K
1-year change:
-80.21%
Market cap:
$8.9M
Revenue:
--
EPS (TTM):
-$0.87
Earnings Data
Next earnings date for ACXP
May 15
2025
Most recent earnings per share
-$0.16
Beat by $0.02
(Mar 18/2025)
Consensus Estimate
-$0.18
(Mar 18/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ACXP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.29 | -- |
| 05/15/2025 | Q1 | -- | -- | -- | -$0.14 | -- |
| 03/18/2025 | Q4 | -- | -- | -$0.16 | -$0.18 | $0.02 |
| 11/13/2024 | Q3 | -- | -- | -$0.17 | -$0.23 | $0.06 |
| 08/09/2024 | Q2 | -- | -- | -$0.26 | -$0.28 | $0.02 |
| 05/15/2024 | Q1 | -- | -- | -$0.28 | -$0.24 | -$0.04 |
| 03/18/2024 | Q4 | -- | -- | -$0.38 | -$0.26 | -$0.12 |
| 11/14/2023 | Q3 | -- | -- | -$0.24 | -$0.25 | $0.01 |
| 08/14/2023 | Q2 | -- | -- | -$0.28 | -$0.23 | -$0.05 |
| 05/12/2023 | Q1 | -- | -- | -$0.25 | -$0.25 | -- |
| 03/16/2023 | Q4 | -- | -- | -$0.28 | -$0.31 | $0.03 |
| 11/14/2022 | Q3 | -- | -- | -$0.32 | -- | -- |
| 08/16/2022 | Q2 | -- | -- | -$0.26 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.26 | -- | -- |
| 03/17/2022 | Q4 | -- | -- | -$0.22 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$0.46 | -- | -- |
| 08/17/2021 | Q2 | -- | -- | -$0.57 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.15 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.11 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.14 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.10 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.13 | -- | -- |
Acurx Pharmaceuticals Earnings Questions
-
How Much did Acurx Pharmaceuticals Generate in Revenue Last Quarter?
Acurx Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Acurx Pharmaceuticals Beat Earnings Last Quarter?
Acurx Pharmaceuticals announced earnings per share of -$0.16 which represents a beat of analyst forecast a -$0.18 per share.
-
Is Acurx Pharmaceuticals Profitable?
Acurx Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Acurx Pharmaceuticals EPS Next Year?
Acurx Pharmaceuticals's earnings are forecast to decrease from -$0.87 per share to -$0.89 per share next year representing a decrease of -2.87%.
-
When is Acurx Pharmaceuticals's Earnings Date?
Acurx Pharmaceuticals's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should You Buy Alibaba Stock Despite the Risks?
Markets rebounded slightly after U.S. President Donald Trump announced a…
Why Is Intel Struggling Against AMD?
Due to its disappointing reports, so-so management, and lack of…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 36x
Alerts
Sell
48
FI alert for Apr 25
Fiserv [FI] is up 1.27% over the past day.
Buy
66
FARO alert for Apr 25
Faro Technologies [FARO] is down 0.16% over the past day.
Buy
55
PI alert for Apr 25
Impinj [PI] is up 3.01% over the past day.
